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Abstract
Background: Poor sleep quality and depression negatively impact the health-related quality of life of patients with
type 2 diabetes, but the combined effect of the two factors is unknown. This study aimed to assess the interactive
effects of poor sleep quality and depression on the quality of life in patients with type 2 diabetes.
Methods: Patients with type 2 diabetes (n = 944) completed the Diabetes Specificity Quality of Life scale (DSQL)
and questionnaires on sleep quality and depression. The products of poor sleep quality and depression were added
to the logistic regression model to evaluate their multiplicative interactions, which were expressed as the relative
excess risk of interaction (RERI), the attributable proportion (AP) of interaction, and the synergy index (S).
Results: Poor sleep quality and depressive symptoms both increased DSQL scores. The co-presence of poor sleep
quality and depressive symptoms significantly reduced DSQL scores by a factor of 3.96 on biological interaction
measures. The relative excess risk of interaction was 1.08. The combined effect of poor sleep quality and depressive
symptoms was observed only in women.
Conclusions: Patients with both depressive symptoms and poor sleep quality are at an increased risk of reduction
in diabetes-related quality of life, and this risk is particularly high for women due to the interaction effect. Clinicians
should screen for and treat sleep difficulties and depressive symptoms in patients with type 2 diabetes.
Keywords: Type 2 diabetes mellitus, Sleep quality, Depression, Diabetes specificity quality of life scale, Interaction,
Relative excess risk of interaction, Attributable proportion, Synergy index
Background
With an alarmingly increasing rate worldwide, diabetes
mellitus in adults is predicted to reach approximately
592 million by 2035 [1]. In China, the prevalence of
diabetes is also increasing rapidly, affecting approxi-
mately 11.6 % of the Chinese population and making
the disease an important public health problem [2]. Pa-
tients with diabetes require lifelong and comprehensive
self-management, including dietary restrictions, frequent
physical exercise to maintain optimal weight, medication
compliance, and blood-glucose monitoring [3]. In such
a long-term self-management process, many patients
experience emotional burdens and poor sleep quality in
response to these prolonged requirements. Burdens in-
clude worry about complications, fear of hypoglycemia,
feelings of guilt regarding uncontrolled blood glucose,
and depressed mood [4].
Depression is one of the most common co-morbidities
among patients with diabetes [5, 6], and those who have
diabetes with comorbid depression tend to have more
diabetes-related complications [7], which also lead to
greater dysfunction [8] and worse quality of life [9–12]
compared with patients who have normal mood states.
Depression with diabetes also represents increased health
care costs [5, 6], and even prompts a higher rate of prema-
ture death when compared with either condition alone
[13]. Poor sleep quality is another common feature of type
2 diabetes [14]. It has been reported that more than half
of patients with diabetes have poor sleep quality [15]. Poor
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sleep quality was significant in predicting diabetes-related
quality of life after controlling for age, years since diabetes
diagnosis, number of comorbidities, number of diabetic
complications, insulin use, and depressive symptoms
[15, 16], and worse physical, mental, and functional
outcomes in adults with type 2 diabetes [17].
Although poor sleep quality and depression have been
shown to be individually correlated to quality of life in
people with type 2 diabetes, to the best of our know-
ledge, no studies have been done on the interaction of
sleep quality and depressive symptoms as they relate to
quality of life in patients with type 2 diabetes. Hence,
the aims of the current study were twofold. A first aim
was to examine the joint effects of poor sleep quality
and depressive symptoms on quality of life in adult
patients with type 2 diabetes in primary care in China.
The prevalence and severity of poor sleep quality and
depression symptoms may differ according to sex [6, 18].
Therefore, a second aim of this study was to assess the
interaction of sleep quality combined depression symptom




The method of patient selection has been described
previously [19]. Briefly, from August to December 2012,
944 type 2 diabetes patients from 37 communities met
the criteria and were enrolled in an observational study.
Diagnostic criteria of patients with diabetes was consist-
ent with the recommendations of the American Diabetes
Association [20]. The following exclusion criteria were
used by our study: 1) diagnosis of type 2 diabetes was
made by a physician at least six months prior to study
enrollment; 2) type 1 diabetes; 3) painful diabetic sensory
neuropathology; 4) diagnosed sleep disorders prior to
diabetes; 5) mental illness or use of any psychotropic
medication; 6) working night shifts in the past 3 months
or travelling across time zones within the past month;
7) other endocrine disorders, such as, thyroid disease
or chronic use of glucocorticoids; 8) age <18 years; 9)
pregnancy or lactation.
Written informed consent was obtained from all par-
ticipants. The study was approved by the ethics com-
mittee of Xuzhou Center for Disease Control and
Prevention (2011710). The procedures followed were in
accordance with the standards of the ethics committee of
Xuzhou Center for Disease Control and Prevention and
with the Declaration of Helsinki (1975, revised 2000).
Sleep quality
Sleep quality was measured using the Pittsburgh Sleep
Quality Index (PSQI) [21]. The PSQI is a 19-item self-
report measure of sleep quality and degree of sleep
difficulties over the past month and contains seven com-
ponent scales: sleep quality, sleep latency, sleep duration,
sleep efficiency, sleep disturbances, use of sleep medica-
tion, and daytime dysfunction. The 7 component scores
are then summed to yield a global PSQI score with a
range of 0–21; higher scores indicate worse sleep quality.
The Chinese version of the PSQI used in this study has
been approved by the original PSQI authors. A global
PSQI score >7 had a diagnostic sensitivity of 98.3 % and
specificity of 90.2 % in distinguishing normal subjects
from patients with sleep quality problems. The good clin-
ical practice and psychometric properties of the PSQI
suggest its usefulness in both Chinese psychiatric clinical
practice and research activities [22]. In our study, a PSQI
score <7 and ≥ 7 were defined as ‘good sleep quality’ and
‘poor sleep quality’, respectively.
Self-rating Depression Scale
The Self-rating Anxiety Scale (SAS) and Self-rating Depres-
sion Scale (SDS) assessed anxiety and depression [23, 24].
Both scales have demonstrated adequate reliability and
validity for the Chinese population [25]. Each of the two
scales included 20 questions, and each question was scored
on a 4-point frequency scale (1, rarely; 2, some of the time;
3, very often/often; 4, almost always). The total score from
the 20 questions was multiplied by 1.25, with the integer
score as a standard score. Cutoffs for both anxiety and
depression were standard scores ≥50.
Other variables
Age, gender, marital status, physical activities, net house-
hold income, level of education, cigarette smoking, alco-
hol consumption, years since diabetes diagnosis, number
of comorbidities, number of diabetic complications, and
insulin use were assessed using a self made question-
naire with face to face interview at their homes by our
study group. The number of diabetic complications was
determined by assessing whether participants reported
their diagnosed coronary artery disease, peripheral vas-
cular disease, stroke, nephropathy, retinopathy, or neur-
opathy. All fasting venous blood samples were drawn
between 8:00 AM and 9:00 AM. HbA1c levels were
assayed using high-performance liquid chromatography
(BIO-RAD Diagnostic Group, CA, USA) by our study
group. We used the level of HbA1c as the index for
glycemic control. HbA1c ≤6.5 % (48 mmol/mol) was
defined as good glycemic control, based on the Chinese
Type 2 Diabetes Prevention and Control 2010 Guide-
lines, while a level >6.5 % was considered poor glycemic
control [26]. Body height (to the nearest 0.1 cm) and
weight (to the nearest 0.1 kg) in light indoor clothing
were measured by our group members at clinics. Body
mass index (BMI; in kg/m2) was calculated, and catego-
rized as underweight (<18.5 kg/m2), normal weight
Zhang et al. BMC Family Practice  (2016) 17:40 Page 2 of 7
(18.5−23.9 kg/m2), or overweight/obese (≥24.0 kg/m2)
[27].
Diabetes Specificity Quality of Life Scale (DSQL)
Quality of life was measured using the Diabetes Specifi-
city Quality of Life Scale (DSQL), which is a validated
questionnaire developed by Chen et al. [28]. to assess life
quality of type 2 diabetes patients in China. The scale
includes 24 items with 4 domain scores that reflect
problems with quality of life in the areas of Physiology,
Psychology, Social, and Therapy. The sum of the scores
for these 4 components produces a global quality of life
score with a range of 24–120 points, where higher scores
indicate worse quality of life. A DSQL score <40 had a
diagnostic sensitivity of 94.5 % and specificity of 91.0 %
in differentiating good from poor quality of life [28].
Statistical analysis
The computer-based analysis program SPSS version 13.0
was used for all statistical analyses. Differences in con-
tinuous variables were tested using the F-test or the
Student t-test, and differences in categorical variables
were assessed using the Pearson χ2 test. The DSQL
score, which represented quality of life was used as the
dependent variable. The associations of sleep quality and
depressive symptoms with patients’ quality of life were
determined using binary logistic regression. The results
were stratified by sleep quality (good versus poor) and
depression (having depressive symptoms versus not),
and were adjusted for age (continuous), sex, educational
level (less than high school, high school, or higher),
marital status, physical activities (yes or no), net house-
hold income (continuous), cigarette smoking (yes or no),
alcohol consumption (yes or no), years since diabetes
diagnosed (continuous), comorbidities (yes or no), dia-
betic complications (yes or no), anxiety (yes or no), insu-
lin use (yes or no), and glycemic control (yes or no). A
cross-product interaction term was included in the logis-
tic regression model to assess multiplicative interactions.
Odds ratios (ORs) and 95 % confidence intervals (CIs)
were calculated using the contrast statement in SPSS
16.0. Variance was calculated using the Taylor series
linearization method, which leads to an asymptotically
unbiased estimate. All associations reported were statis-
tically significant (P <0.05) using two-tailed tests.
To estimate the biological interaction between sleep
quality and presence or absence of depression, we created
three new variables: 1) PSQI global score <7 = no and
depression = yes; 2) PSQI global score ≥7 = yes and
depression = no; and 3) PSQI global score ≥7 = yes
and depression = yes [29, 30].
The relative excess risk due to interaction (RERI), the
attributable proportion due to interaction (AP), and the
synergy index (S) were used to estimate biological
interactions [30]. The RERI is the excess risk attributed
to interaction relative to the risk without exposure. AP
refers to the attributable proportion of disease caused by
interaction in subjects with both exposures. S is the
excess risk from both exposures when there is a bio-
logical interaction relative to the risk from both expo-
sures without interaction. In the absence of additive
interactions, RERI and AP are equal to 0 [31]. The
current study refined the criteria as either a statistically
significant RERI >0, AP >0, or S >1 to indicate biological
interactions.
Subgroup analysis: A final set of logistic regression
analyses were performed to assess whether the associ-
ation between sleep quality and depression symptom
level would vary as a function of gender. Regression
analyses and interaction analyses were conducted for
female and male subjects separately.
Results
General characteristics of participants
The mean age of participants was 64.1 ± 10.2 years, and
61.3 % were female. 56 patients were unanswered,
there was accounted for 5.6 %. The mean age of non-
respondents was 63.8 ± 10.1 years, and 59.9 % were
female. There were no significant differences between
participants and non-respondents (P >0.05). The average
DSQL was 50.7 ± 12.9, and males had lower DSQL scores
than did females (48.8 ± 12.7 vs 51.9 ± 13.1, P <0.01). A
total of 19.9 % of the sample reported having good quality
of life. Men were more likely to report having good quality
of life than were women (32.3 % vs. 12.1 %, P<0.001).
Within the sample, 17.3 % were smokers, 12.0 % were
alcohol drinkers, 64.2 % did not have any comorbidity,
and 12.4 % were treated with insulin. Participants had an
average duration of 5.6 ± 5.1 years since type 2 diabetes
had been diagnosed. The distribution of general character-
istics of participants was presented in Table 1.
Rates of poor sleep quality and depressive symptoms
The prevalence of poor sleep quality of the participants
was 33.6 %. Women were slightly more likely than men
to report having poor sleep quality (46.1 % vs. 37.8 %). A
large fraction of participants, 40.1 %, had depressive
symptoms, and 65.5 % had anxiety symptoms. Women
had more depressive symptoms (43.4 % vs. 35.1 %) and
anxious symptoms (72.4 % vs. 54.5 %) than did men.
The rate of poor sleep quality was 21.3 % (40/188) in
patients with good quality of life and 48.3 % (365/756) in
patients with poor quality of life (χ2 = 44.82, P <0.01).
The prevalence of depressive symptoms was 26.6 %
(50/188) in patients with good quality of life and
43.5 % (329/756) in patients with poor quality of life
(χ2 = 17.94, P <0.01). The rates of poor sleep quality
and depressive symptoms were lower in patients with
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good quality of life than in patients with poor quality
of life, regardless of gender (Table 1).
Correlations of PSQI scores and SDS scores with DSQL
The correlations between PSQI and DSQL scores, and
between SDS and DSQL scores were positive, with
correlation coefficients of 0.386, 0.364 (all P <0.001),
respectively. Separate correlation analyses were conducted
for male and female subjects. For men, the correlation
coefficients between PSQI scores and DSQL scores, and
between SDS scores and DSQL scores, respectively, were
0.395, 0.337 (all P <0.001). For women, these values were
0.341, 0.371 (all P <0.001), respectively.
Biological interaction of sleep quality and depressive
symptoms in quality of life of patients with type 2
diabetes
The results from the multiple logistic regression models
are presented in Table 2 to reveal interaction using a
combined effects method. Diabetic patients with poor
sleep quality and no depressive symptoms had a 2.77-
fold higher risk of reduced health status as indicated by
the DSQL score compared with patients who had neither
poor sleep quality nor depressive symptoms. Only depres-
sive patients who were good sleepers also had reduced
health status compared with that of patients who had
neither poor sleep nor depressive symptoms (OR: 1.15;
95 % CI: 1.05–1.65). Diabetic patients who had both poor
sleep quality and depressive symptoms had a 3.96-fold
increased risk of reduced health status as measured by the
DSQL, compared with those who neither slept poorly nor
had depression. Separate regression analyses were con-
ducted for male and female participants. For men, poor
sleep quality played a greater role in reducing DSQL than
did depressive symptoms; for women, depressive symp-
toms played the larger role. The combined effect of poor
sleep quality and depressive symptoms produced greater
reductions in DSQL for women than for men (see
Table 2).
Sensitivity analysis
There was an additive interaction between poor sleep
quality and presence of depressive symptoms (RERI, 1.08;
95 % CI: 0.74–2.01) in the sample at large (Table 3): the
OR of reduced DSQL score in patients with both poor
sleep quality and depressive symptoms was 1.08 times
higher than that of good sleepers who did not have
depression, with 27 % of declining health status attributed
to the interaction of sleep quality and depression. For
men, there was no interaction between poor sleep quality
and depressive symptoms (RERI, −0.42; 95 % CI: −1.12–
0.01). For women, there was an additive effect (RERI, 1.85;
95 % CI: 1.23–3.01), with 44 % of declining health status
attributed to the interaction between poor sleep quality
and depression.
Table 1 The distribution of general characteristics of quality of life by gender
Variables Men (n = 365) Women (n = 579)
Good Poor P Good Poor P
n = 118 N = 247 n = 70 n = 509
Age >60 62.1 ± 8.7 65.6 ± 10.6 0.002 61.6 ± 9.8 65.5 ± 11.1 0.006
Above high school 14(11.86) 39(15.79) 0.319 5(7.14) 27(5.30) 0.725
No spouse 18(15.25) 56(22.67) 0.099 8(11.43) 73(14.34) 0.51
Regular exercise 105(88.98) 193(78.14) 0.012 60(85.71) 396(68.39) 0.129
Income below population average (%) 49(41.53) 125(50.60) 0.104 46(65.71) 269(52.85) 0.043
BMI 24.1 ± 2.5 23.8 ± 2.9 0.335 24.0 ± 2.5 23.8 ± 2.8 0.571
Median of disease duration (years) 3.8 ± 3.6 6.2 ± 5.1 <0.01 3.8 ± 3.7 6.1 ± 5.4 <0.01
Comorbidities 23(19.49) 107(43.32) <0.01 24(34.29) 184(36.15) 0.761
Complications 10(8.47) 71(28.74) <0.01 3(4.29) 155(30.45) <0.01
Smokers 30(25.42) 105(42.51) 0.002 7(10.00) 21(4.13) 0.064
Drinkers 26(22.03) 61(24.70) 0.577 8(11.43) 18(3.54) 0.007
Depression 33(27.97) 95(38.46) 0.049 17(24.29) 234(45.97) 0.001
Anxiety 37(31.36) 162(65.59) <0.01 49(70.00) 370(72.69) 0.637
Using insulin 4(3.39) 37(14.98) 0.001 2(2.86) 74(14.54) 0.007
HbA1c <6.5 % 36(30.51) 35(14.17) <0.01 24(34.29) 69(13.56) <0.01
PSQI≥ 8 25(21.19) 113(45.75) <0.01 15(21.43) 252(49.51) <0.01
BMI Body mass index; HbA1c Glycated hemoglobin; DSQL Diabetes Specificity Quality of Life Scale. Comorbidity refers to disease accompanying diabetes;
Complication refers to a disease caused by diabetes; PSQI Pittsburgh Sleep Quality Index
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Discussion
This study produced three main findings. First, an inter-
action effect of poor sleep quality and depressive symp-
toms in increasing DSQL scores of type 2 diabetes
patients was observed. Second, this interaction only
existed for women. Third, poor sleep quality alone pro-
duced a greater addition of DSQL scores in our sample
than did depressive symptoms alone.
Sleep disorders and depression are in close relation-
ship. An epidemiological survey has shown that more
than 90 % of patients with depression will have a sleep
disorder, and that patients with depression usually have
difficulties falling asleep, awaken frequently during the
night, awaken early, and experience non-refreshing sleep
[32, 33]. Conversely, sleep disorders can also cause de-
pression: in one study, 41 % of patients experienced a
sleep disorder before a major depressive disorder, and
approximately 29 % of patients experienced sleep disor-
ders and depression simultaneously [32, 34]. In the
present study, we found for the first time a combined
effect of poor sleep quality and depression in DSQL
score additions of patients with type 2 diabetes; i.e.,
DSQL scores were higher for patients with both poor
sleep quality and depressive symptoms than for patients
experiencing only one of these difficulties.
Depression and poor sleep quality may affect quality
of life of patients with diabetes through either patho-
physiologic or behavioral pathways. Pathophysiologic
pathways of both poor sleep and depression involve
dysregulation in the fronto-limbic system and reductions
in hippocampal volume [33, 35]. These in turn lead to
dysregulation of the hypothalamic-pituitary adrenal axis
and the autonomic nervous system, inducing increases
in glucocorticoids secretion, alterations in glucose trans-
port function, and increased immunoinflammatory acti-
vation [36], which results in elevated blood glucose.
Behavioral pathways of depression and poor sleep include
insufficient diabetes self care, poor diet, and persistent
poor glycemic control [37–40]. Taken together, these
factors produce a vicious cycle that decreases the quality
of life of patients with type 2 diabetes.
When the interaction between poor sleep quality and
depression symptoms was assessed separately for men
and women, an important gender difference emerged:
this interaction only produced lower quality of life in
women. The hormone theory provides a useful frame-
work for interpreting this finding. After the age of 30 years,
estrogen decreases gradually in women [41] and results in
a decline in well-being [42]. Decreased estrogen can also
aggravate insomnia. According to this theory, lower qual-
ity of life results from a combination of factors including
insomnia and the decline in well-being. An alternative
explanation for this finding is the higher prevalence of
poor sleep quality and depression in women than in men
in our study.
Our study showed a strong negative association between
depression and health-related quality of life in patients
with type 2 diabetes, which consistent with previous re-
ports [9–12]. Not surprisingly, we also found that PSQI
and DSQL scores were strongly associated. Poor sleep
quality of patients with type 2 diabetes has been shown to
predict a lower quality of life [15–17]. However, poor sleep
quality produced greater reductions in DSQL scale than
did depressive symptoms. This may support that sleep
quality has an important role in mediating the way in





















Good <50 76 107 1 47 212 1 123 319 1
Good ≥50 17 27 1.10(1.03 ~ 1.55) 8 45 1.19(1.07 ~ 1.62) 25 72 1.15(1.05 ~ 1.65)
Poor <50 9 45 3.27(2.42 ~ 4.78) 6 63 2.11(1.83 ~ 5.16) 15 108 2.77(1.42 ~ 6.28)
Poor ≥50 16 68 2.95(2.58 ~ 5.14) 9 189 4.15(3.12 ~ 9.96) 25 257 3.96(1.58 ~ 5.74)
§Models were adjusted for age, sex, disease duration, marital status, income, education level, smoking status, comorbidity, anxiety
Table 3 Measures for estimating biological effects on the
combination of sleep quality and depressive symptoms on the
reduction of quality of life in patients with type 2 diabetes
Measures of biological
interaction




RERI −0.42(−1.12-0.01) 1.85(1.23-3.01) 1.08(0.74-2.01)
AP −0.14(−0.31-0.19) 0.44(0.25-0.67) 0.27(0.13-0.51)
S 0.82(0.27-1.56) 2.42(1.48-4.11) 1.57(1.12-2.17)
Reference group is sleep quality score <8 and depressive symptom score < 50
Models were adjusted for age, sex, education level, marital status, exercise,
income, BMI, disease duration, co-morbidity, complication, smoking. drinking,
insulin use, and anxiety
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which psychological distress affects quality of life for those
with diabetes [43].
Strengths of our study include the homogeneity of the
random sample, large sample size, and the community-
based nature of the sample. Limitations include the
reliance on self-reported measures of poor sleep quality
and depression levels. Also, owing to the cross-sectional
nature of this sample, the temporal order of causality
cannot be argued conclusively. Third, although we used
reliable and valid measures of anxiety and depression,
these measures did not constitute a clinical diagnosis of
poor sleep quality or of depression disorder. Fourth, we
were unable to adjust for other confounds, such as
hypoglycemia. Fifth, these findings were only derived
from Chinese patients and need to be replicated in other
ethnic populations.
Implications
Despite these limitations, we believe that our results
have great significance for public health. In fully adjusted
models, we estimated that 27 % (44 % in women) of the
addition in DSQL of patients with type 2 diabetes can be
explained by an interaction between poor sleep quality
and depressive symptoms. The finding suggests that clini-
cians should screen for and treat depression complaints
and poor sleep quality in these patients. Efficacious be-
havioral and pharmacologic treatments exist for both
depression disorders and poor sleep quality [44, 45].
Identification and implementation into routine health
care for integrated health services for comorbid depres-
sion and diabetes in different types of service and in
different countries [46]. The application of either a de-
pression- or sleep-focused intervention could produce
relief in both symptoms, thereby maximizing improve-
ments in patients’ quality of life. Given the difficulty in
treating poor sleep quality or depression in certain
patients, recommendations that help prevent poor sleep
quality and depression are an inexpensive and practical
means of improving DSQL for patients with type 2
diabetes.
Conclusions
Our study showed a strong negative association between
depression and health related quality of life in patients
with type 2 diabetes. And we found that PSQI and
DSQL scores were strongly associated. Patients with
both depressive symptoms and poor sleep quality are at
an increased risk of reduction in diabetes-related quality
of life. Clinicians should screen for and treat sleep diffi-
culties and depressive symptoms in patients with type 2
diabetes.
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